Kevin Lilly is the former Senior Vice President of Sales at MiMedx, which distributes regenerative therapeutic products to medical practitioners in physician’s offices, outpatient clinics, hospitals, and VA facilities. During the course of his tenure, Kevin Lilly grew company sales from $187 million to $385 million.
Several of the company’s products rely on its PURION process for extracting growth factors and bioactive proteins used in human amniotic membrane allografts. The PURION process involves removing the blood factors while making sure to leave the amniotic membrane intact. This allows for the safe separation, cleaning, reassembly, and dehydration of placental tissues in a manner that preserves their healing properties.
The human amniotic membrane is a multi-layered tissue which is comprised of a single layer of epithelial cells as well as avascular connective tissue and a basement membrane. This membrane contains collagens that are commonly associated with cell growth. It also contains specialized proteins within an extracellular matrix and various growth factors. Through the PURION cleaning process, this tissue becomes a durable graft that can be used for reconstructive surgical procedures and wound care.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.